These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36576239)

  • 1. Reconceptualizing the clinicopathological features, locoregional therapy and prognostic factors of occult breast cancer in the era of molecular subtyping.
    Ye X; Yang L; He Q; Lin X; Wang J; Cui R; Xu C
    Women Health; 2023 Feb; 63(2):105-114. PubMed ID: 36576239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
    Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
    J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node dissection plus radiotherapy may be an optimal strategy for patients with occult breast cancer.
    Li L; Zhang D; Wen T; Wu Y; Lv D; Zhai J; Ma F
    J Natl Cancer Cent; 2022 Dec; 2(4):198-204. PubMed ID: 39036544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study.
    Zhao Z; Zhang T; Yao Y; Lu X
    BMC Surg; 2022 Apr; 22(1):143. PubMed ID: 35430796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study.
    Ge LP; Liu XY; Xiao Y; Gou ZC; Zhao S; Jiang YZ; Di GH
    Cancer Manag Res; 2018; 10():4381-4391. PubMed ID: 30349371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer.
    He M; Tang LC; Yu KD; Cao AY; Shen ZZ; Shao ZM; Di GH
    Eur J Surg Oncol; 2012 Nov; 38(11):1022-8. PubMed ID: 22959166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database.
    Hessler LK; Molitoris JK; Rosenblatt PY; Bellavance EC; Nichols EM; Tkaczuk KHR; Feigenberg SJ; Bentzen SM; Kesmodel SB
    Ann Surg Oncol; 2017 Oct; 24(10):2907-2914. PubMed ID: 28766198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.
    Walker GV; Smith GL; Perkins GH; Oh JL; Woodward W; Yu TK; Hunt KK; Hoffman K; Strom EA; Buchholz TA
    Cancer; 2010 Sep; 116(17):4000-6. PubMed ID: 20564117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features, psychological status, and prognosis of 33 patients with occult breast cancer.
    Wang HM; Yu AY; Li LL; Ma LY; Cao MH; Yang YL; Qin XB; Tang JJ; Han ZX
    World J Psychiatry; 2024 Jan; 14(1):76-87. PubMed ID: 38327892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.
    Qu J; Li C; Liu M; Wang Y; Feng Z; Li J; Wang W; Wu F; Zhang S; Zhao X
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.
    Cohen BL; Collier AL; Kelly KN; Goel N; Kesmodel SB; Yakoub D; Moller M; Avisar E; Franceschi D; Macedo FI
    Ann Surg Oncol; 2020 Jun; 27(6):1830-1841. PubMed ID: 31989360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.
    Man X; Xu H; Wang H; Zhao J; Chen X; Yin S; Tan Q; Huang J; Sun S; Zhou D; Zheng F; Liu T; Song L; Zhang B; Li N; Li H
    Ann Transl Med; 2022 Dec; 10(24):1351. PubMed ID: 36660717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Clinicopathological Characteristics and Prognostic Factors for Occult and Non-occult Breast Cancer: Analysis of the SEER Database.
    Huang KY; Zhang J; Fu WF; Lin YX; Song CG
    Front Oncol; 2020; 10():1420. PubMed ID: 32974151
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI.
    Kim H; Park W; Kim SS; Ahn SJ; Kim YB; Kim TH; Kim JH; Choi JH; Park HJ; Chang JS; Choi DH
    Breast; 2020 Feb; 49():63-69. PubMed ID: 31734590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis.
    Macedo FI; Eid JJ; Flynn J; Jacobs MJ; Mittal VK
    Ann Surg Oncol; 2016 Jun; 23(6):1838-44. PubMed ID: 26832884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable Survival between Additional Radiotherapy and Local Surgery in Occult Breast Cancer after Axillary Lymph Node Dissection: A Population-based Analysis.
    Wu SG; Zhang WW; Sun JY; Li FY; Lin HX; Chen YX; He ZY
    J Cancer; 2017; 8(18):3849-3855. PubMed ID: 29151972
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenocarcinoma of the Breast Presenting as Occult Breast Cancer With Axillary and Supraclavicular Lymph Node Metastasis: A Case Report.
    Aleman Espino A; Bernal IC; Guarecuco JE; El-Tawil R; Masri MM
    Cureus; 2023 May; 15(5):e39583. PubMed ID: 37384084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database.
    Kim BH; Kwon J; Kim K
    Cancer Res Treat; 2018 Apr; 50(2):551-561. PubMed ID: 28602055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Four Cases of Occult Breast Cancer Treated with Breast Conserving Therapy after Neoadjuvant Chemotherapy].
    Miyoshi T; Shiobara M; Wakatsuki K; Arai S; Suda K; Miyazawa K; Aida T; Takahashi Y; Yoshioka S
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1149-1151. PubMed ID: 29394563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.